* Newstin.com is for sale! * After achieving our strategic milestone, we are offering for sale: Newstin.com and all 14 related domains featuring 1 million unique visitors per month + continuously updated news database of 37 million articles in 12 world languages from 166,000 global and weighted sources + 2.1 billion metadata * To seize this unique chance, contact invest@newstin.com. * Newstin.com is for sale! *

Memory Pharmaceuticals

Memory Pharmaceuticals Schedules May 14 Earnings Call

tmcnet.com
May 8, 2008
        

Memory Pharmaceuticals Schedules May 14 Earnings Call ... May 8, 2008 (FinancialWire) Memory Pharmaceuticals Corp. (NASDAQ: MEMY) (Current Market Cap: US$ 28.36 Mil.) will release its first quarter 2008 financial results on May 14, before the U.S. financial markets open....

add comment

Memory Pharmaceuticals to Announce First Quarter 2008 Results on Wednesday, May 14, 2008

finanznachrichten.de
May 7, 2008 3 related
        

MONTVALE, N.J., May 7 /PRNewswire-FirstCall/ - Memory Pharmaceuticals Corp. announced today that it will report its first quarter 2008 financial results ... ... MONTVALE, N.J., May 7 /PRNewswire-FirstCall/ -- Memory Pharmaceuticals Corp. announced today that it will...

add comment

Roche exercises option to develop Memory's neurological drug

pharmaceutical-business-review.com
May 6, 2008
        

Roche has exercised its option to further develop and commercialize Memory Pharmaceuticals's lead nicotinic alpha-7 agonist drug candidate, MEM 3454, for neurological and psychiatric disorders. ... Roche's exercise of its option triggers a $6 million milestone payment...

add comment
                   

OTCPicks.com: OTCPicks.com Daily Market Movers Digest Midday Report for Friday, May 2nd MGRN,...

tmcnet.com
May 2, 2008 1 related
        

OTCPicks.com: OTCPicks.com Daily Market Movers Digest Midday Report for Friday, May 2nd MGRN, PIII, EXPT, MEMY, TRXI ... Our Stocks to Watch today include Monogram Energy Inc. (OTC: MGRN), PECO II Inc. (NASD: PIII), Expert Group Inc. (OTC: EXPT), Memory Pharmaceuticals...

add comment
                   

Biomedicine: Prix Galien USA Welcomes Eighth Nobel Laureate to its Prestigious Award Committee

newsrx.com
Apr 29, 2008
        

Nobel Laureate Walter Gilbert, Ph.D., the Carl M. Loeb University Professor Emeritus at Harvard University and founder of Biogen, has joined fellow Nobel Laureates on the committee responsible for awarding the most coveted prize in biopharmaceutical research. Prix Galien USA 2008...

add comment

Memory Pharmaceuticals Corp. Announces Departure of President Dr. Axel Unterbeck

pharmiweb.co.uk
Apr 8, 2008 2 related
        

Previous Page Page 1 Next Page SciClone Pharmaceuticals Announces Departure Of Richard Waldron As CFO Friday, 4 Apr 2008 05:36pm EDT SciClone Pharmaceuticals announced that its Executive Vice President and Chief Financial Officer(CFO), Richard Waldron, has communicated...

add comment

Memory Pharmaceuticals Receives Nasdaq Notification

redorbit.com
Apr 4, 2008 20 related
        

MONTVALE, N.J., April 4, 2008 /PRNewswire-FirstCall/ -- Memory Pharmaceuticals Corp. ... today announced that on April 2, 2008, it received notice from The Nasdaq Stock Market stating that the Company is no longer in compliance with the minimum $10.0 million...

add comment

Memory Pharmaceuticals Gets Non-compliance Notice From Nasdaq - Quick Facts [MEMY]

pharmiweb.co.uk
Apr 4, 2008 1 related
        

RTTNews.com ... 4/4/2008 4:15:48 PM Memory Pharmaceuticals Corp. (MEMY) said Friday it has received notice from the Nasdaq Stock Market stating that the company is no longer in compliance with the minimum $10.0 million stockholders' equity requirement for continued...

add comment

Memory Pharmaceuticals Corp. Presents Data For MEM 3454 and MEM 1003

pharmiweb.co.uk
Apr 4, 2008 6 related
        

Previous Page Page 1 Next Page Clavis Pharma ASA Announces Success of Phase I Study of ELACYT and Starts Phase II Study Thursday, 3 Apr 2008 06:09am EDT Clavis Pharma ASA announced that it has started its phase II study of ELACYT, within hematological cancers. Topotarget...

add comment

Memory Pharmaceuticals Receives Audit Opinion Containing Going Concern Qualification

redorbit.com
Mar 28, 2008 18 related
        

MONTVALE, N.J., March 28 /PRNewswire-FirstCall/ -- Memory Pharmaceuticals Corp. ... today reported that the Company's independent registered public accounting firm included an explanatory paragraph in their opinion on the Company's financial statements included in the...

add comment